𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCV72 COST-EFFECTIVENESS OF EXTENDED-RELEASE NICOTINIC ACID/ LAROPIPRANT AS MONOTHERAPY VERSUS EZETIMIBE MONOTHERAPY IN PATIENTS WITH MIXED DYSLIPIDAEMIA IN SCOTLAND

✍ Scribed by K Jameson; GM Davies; BM Ambegaonkar; V Sazonov; C O'Regan


Book ID
118614609
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
76 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.